Soliton, Inc. (SOLY) relating to its proposed acquisition by Allergan Aesthetics, an AbbVie company. Under the terms of the agreement, SOLY shareholders will receive $22.60 in cash per share.
Soliton, Inc. (SOLY) relating to its proposed acquisition by Allergan Aesthetics, an AbbVie company. Under the terms of the agreement, SOLY shareholders will receive $22.60 in cash per share.